WallStreetZenWallStreetZen

NASDAQ: PRE
Prenetics Global Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for PRE

Based on 1 analyst offering 12 month price targets for Prenetics Global Ltd

Min Forecast
$32.00+97.17%
Avg Forecast
$32.00+97.17%
Max Forecast
$32.00+97.17%

Should I buy or sell PRE stock?

Based on 1 analyst offering ratings for Prenetics Global Ltd.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their PRE stock forecasts and price targets.

PRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-29

1 of 1

Forecast return on equity

Is PRE forecast to generate an efficient return?

Company
47.25%
Industry
10.94%
Market
358.82%
PRE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PRE forecast to generate an efficient return on assets?

Company
38.78%
Industry
11.71%
PRE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PRE earnings per share forecast

What is PRE's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$1.54
Avg 2 year Forecast
$5.48

PRE revenue forecast

What is PRE's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$219.4M+230.78%
Avg 2 year Forecast
$382.7M+477.04%
PRE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRE revenue growth forecast

How is PRE forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
230.78%
Industry
9.49%
Market
1,557%
PRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRE vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
PRE$16.23$32.00+97.17%Strong Buy
IMDX$6.15$9.00+46.34%Buy
SERA$3.48N/AN/A
STIM$1.94$7.00+261.76%Strong Buy
FONR$18.73N/AN/A
View Top Diagnostic & Research Stocks

Prenetics Global Stock Forecast FAQ

Is Prenetics Global Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PRE) stock is to Strong Buy PRE stock.

Out of 1 analyst, 1 (100%) are recommending PRE as a Strong Buy, 0 (0%) are recommending PRE as a Buy, 0 (0%) are recommending PRE as a Hold, 0 (0%) are recommending PRE as a Sell, and 0 (0%) are recommending PRE as a Strong Sell.

If you're new to stock investing, here's how to buy Prenetics Global stock.

What is PRE's earnings growth forecast for 2026-2027?

(NASDAQ: PRE) Prenetics Global's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 46.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,315.06%.

Prenetics Global's earnings in 2026 is -$46,551,000.On average, 2 Wall Street analysts forecast PRE's earnings for 2026 to be $21,332,209, with the lowest PRE earnings forecast at $20,698,579, and the highest PRE earnings forecast at $22,177,049.

In 2027, PRE is forecast to generate $76,206,509 in earnings, with the lowest earnings forecast at $73,942,950 and the highest earnings forecast at $79,224,589.

What is PRE's revenue growth forecast for 2026-2027?

(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 230.78% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,557%.

Prenetics Global's revenue in 2026 is $66,320,000.On average, 2 Wall Street analysts forecast PRE's revenue for 2026 to be $3,048,232,582, with the lowest PRE revenue forecast at $2,957,773,567, and the highest PRE revenue forecast at $3,168,983,556.

In 2027, PRE is forecast to generate $5,317,628,330 in revenue, with the lowest revenue forecast at $5,159,637,700 and the highest revenue forecast at $5,528,282,503.

What is PRE's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: PRE) forecast ROA is 38.78%, which is higher than the forecast US Diagnostics & Research industry average of 11.71%.

What is PRE's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PRE price target, the average PRE price target is $32.00, with the highest PRE stock price forecast at $32.00 and the lowest PRE stock price forecast at $32.00.

The Wall Street analyst predicted that Prenetics Global's share price could reach $32.00 by Oct 29, 2026. The average Prenetics Global stock price prediction forecasts a potential upside of 97.17% from the current PRE share price of $16.23.

What is PRE's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: PRE) Prenetics Global's current Earnings Per Share (EPS) is -$3.57. On average, analysts forecast that PRE's EPS will be $1.54 for 2026, with the lowest EPS forecast at $1.49, and the highest EPS forecast at $1.60. In 2027, PRE's EPS is forecast to hit $5.48 (min: $5.32, max: $5.70).

What is PRE's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: PRE) forecast ROE is 47.25%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.